Targeting the “hallmarks of aging” to slow aging and treat age-related disease: fact or fiction?
Open accessThe DOI matches its Crossref record; 43 of the 43 references it cites were found in a registry or an index.
Abstract
Aging is a major risk factor for a number of chronic diseases, including neurodegenerative and cerebrovascular disorders. Aging processes have therefore been discussed as potential targets for the development of novel and broadly effective preventatives or therapeutics for age-related diseases, including those affecting the brain. Mechanisms thought to contribute to aging have been summarized under the term the “hallmarks of aging” and include a loss of proteostasis, mitochondrial dysfunction, altered nutrient sensing, telomere attrition, genomic instability, cellular senescence, stem cell exhaustion, epigenetic alterations and altered intercellular communication. We here examine key claims about the “hallmarks of aging”. Our analysis reveals important weaknesses that preclude strong and definitive conclusions concerning a possible role of these processes in shaping organismal aging rate. Significant ambiguity arises from the overreliance on lifespan as a proxy marker for aging, the use of models with unclear relevance for organismal aging, and the use of study designs that do not allow to properly estimate intervention effects on aging rate. We also discuss future research directions that should be taken to clarify if and to what extent putative aging regulators do in fact interact with aging. These include multidimensional analytical frameworks as well as designs that facilitate the proper assessment of intervention effects on aging rate.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
López-Otín, C., Blasco, M. A., Partridge, L., Serrano, M., & Kroemer, G. (2013) · Cell · doi:10.1016/j.cell.2013.05.039 · Cited by 14,982
Telomeres shorten during ageing of human fibroblasts
Harley, C. B., Futcher, A. B., & Greider, C. W. (1990) · Nature · doi:10.1038/345458a0 · Cited by 5,750
Poewe, W., Seppi, K., Tanner, C. M., Halliday, G. M., Brundin, P., Volkmann, J., Schrag, A.-E., & Lang, A. E. (2017) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2017.13 · Cited by 5,415
Ageing as a risk factor for neurodegenerative disease
Hou, Y., Dan, X., Babbar, M., Wei, Y., Hasselbalch, S. G., Croteau, D. L., & Bohr, V. A. (2019) · Nature Reviews Neurology · doi:10.1038/s41582-019-0244-7 · Cited by 3,310 · cited 2×
“The “hallmarks of aging” also inspired many scientists from other fields, including the field of neurodegeneration, to shape their findings in the form of these nine hallmarks [7, 16].”
BackgroundGeroscience: Linking Aging to Chronic Disease
Kennedy, B. K., Berger, S. L., Brunet, A., Campisi, J., Cuervo, A. M., Epel, E. S., Franceschi, C., Lithgow, G. J., Morimoto, R. I., Pessin, J. E., et al. (2014) · Cell · doi:10.1016/j.cell.2014.10.039 · Cited by 2,764
IGF-1 receptor regulates lifespan and resistance to oxidative stress in mice
Holzenberger, M., Dupont, J., Ducos, B., Leneuve, P., Géloën, A., Even, P. C., Cervera, P., & Le Bouc, Y. (2003) · Nature · doi:10.1038/nature01298 · Cited by 2,109 · cited 1×
“For growth hormone signaling, we therefore reviewed all available data obtained from studies involving long-lived dwarf and related mouse lines (Ames dwarf [216], Laron dwarf [217], Snell dwarf [218], growth hormone receptor knock-out [219], growth hormone releasing hormone receptor knock-out [218] and Igf1 heterozygo…”
Background2018 Alzheimer's disease facts and figures
Alzheimer's Association (2018) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2018.02.001 · Cited by 1,912
Ageing as a Risk Factor for Disease
Niccoli, T., & Partridge, L. (2012) · Current Biology · doi:10.1016/j.cub.2012.07.024 · Cited by 1,831 · cited 3×
“Advanced age is the main risk factor for many common diseases, such as cancers, cardiovascular disorders, and neurodegeneration [1].”
BackgroundInfluentialLongevity, Stress Response, and Cancer in Aging Telomerase-Deficient Mice
Rudolph, K. L., Chang, S., Lee, H.-W., Blasco, M., Gottlieb, G. J., Greider, C., & DePinho, R. A. (1999) · Cell · doi:10.1016/s0092-8674(00)80580-2 · Cited by 1,349 · cited 3×
“A lifespanshortening effect becomes only evident after multiple rounds of breeding [137, 146], suggesting that only progressive telomere attrition accumulating across multi-generational cell divisions is capable of eliciting effects on lifespan and health-related outcomes in these mouse models.”
BackgroundEssential role of mouse telomerase in highly proliferative organs
Lee, H.-W., Blasco, M. A., Gottlieb, G. J., Horner, J. W., Greider, C. W., & DePinho, R. A. (1998) · Nature · doi:10.1038/33345 · Cited by 1,270 · cited 2×
“A lifespanshortening effect becomes only evident after multiple rounds of breeding [137, 146], suggesting that only progressive telomere attrition accumulating across multi-generational cell divisions is capable of eliciting effects on lifespan and health-related outcomes in these mouse models.”
Background
Research works printed but not linked: 177
- Castillo X, Castro-Obregón S, Gutiérrez-Becker B, Gutiérrez-Ospina G, Karalis N, Khalil AA et al. Re-thinking the etiological framework of neurodegeneration. Front Neurosci. 2019;13. https://doi.org/10.3389/fnins.2019.00728. · DOI · Paper page
- Kaeberlein M, Galvan V, Rapamycin and Alzheimer’s disease: Time for a clinical trial? Sci Transl Med. 2019;11. https://doi.org/10.1126/scitranslmed.aar4289. · DOI · Paper page
- Daniele S, Giacomelli C, Martini C. Brain ageing and neurodegenerative disease: The role of cellular waste management. Biochem Pharmacol. 2018;158:207–16. · DOI · Paper page
- Miller RA Biology of Aging and Longevity. In: Halter JB, Ouslander JG, Tinetti ME, Studenski S, High KP, Asthana S (eds). Hazzard’s Geriatric Medicine and Gerontology, 6th edition edn. McGraw Hill 2009.
- Zhang R, Chen HZ, Liu DP. The four layers of aging. Cell Syst. 2015;1:180–6. · DOI
- Gems D, de Magalhães JP. The hoverfly and the wasp: A critique of the hallmarks of aging as a paradigm. Ageing Res Rev. 2021;70:101407. · DOI · Paper page
- Lemoine M. The evolution of the hallmarks of aging. Front Genet. 2021;12:693071. · DOI
- van der Rijt S, Molenaars M, McIntyre RL, Janssens GE, Houtkooper RH. Integrating the hallmarks of aging throughout the tree of life: a focus on mitochondrial dysfunction. Front Cell Dev Biol. 2020;8:594416. · DOI · Paper page
- Aunan JR, Cho WC, Søreide K. The biology of aging and cancer: a brief overview of shared and divergent molecular hallmarks. Aging Dis. 2017;8:628–42. · DOI · Paper page
- Chmielewski PP. Human ageing as a dynamic, emergent and malleable process: from disease-oriented to health-oriented approaches. Biogerontology. 2020;21:125–30. · DOI
- Guimarães GR, Almeida PP, de Oliveira Santos L, Rodrigues LP, de Carvalho JL, Boroni M, Hallmarks of aging in macrophages: consequences to skin inflammaging. Cells 2021;10. https://doi.org/10.3390/cells10061323. · DOI
- Sun Y, Liu Y, Ma X, Hu H. The influence of cell cycle regulation on chemotherapy. Int J Mol Sci. 2021;22:6923. · DOI · Paper page
- Yao Y, Dai W. Genomic instability and cancer. J Carcinog Mutagen. 2014;5:1000165.
- Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell. 2011;144:646–74. · DOI · Paper page
- Hanahan D, Weinberg RA. The hallmarks of cancer. Cell. 2000;100:57–70. · DOI · Paper page
- Pettan-Brewer C, Treuting PM Practical pathology of aging mice. Pathobiol Aging Age Relat Dis. 2011;1. https://doi.org/10.3402/pba.v1i0.7202. · DOI
- Lipman R, Galecki A, Burke DT, Miller RA. Genetic loci that influence cause of death in a heterogeneous mouse stock. J Gerontol A Biol Sci Med Sci. 2004;59:977–83. · DOI · Paper page
- Miller RA, Harrison DE, Astle CM, Baur JA, Boyd AR, de Cabo R, et al. Rapamycin, but not resveratrol or simvastatin, extends life span of genetically heterogeneous mice. J Gerontol A Biol Sci Med Sci. 2011;66:191–201. · DOI · Paper page
- Xie K, Neff F, Markert A, Rozman J, Aguilar-Pimentel JA, Amarie OV, et al. Every-other-day feeding extends lifespan but fails to delay many symptoms of aging in mice. Nat Commun. 2017;8:155. · DOI · Paper page
- Baker DJ, Dawlaty MM, Wijshake T, Jeganathan KB, Malureanu L, van Ree JH, et al. Increased expression of BubR1 protects against aneuploidy and cancer and extends healthy lifespan. Nat Cell Biol. 2013;15:96–102. · DOI · Paper page
- Weaver RL, Limzerwala JF, Naylor RM, Jeganathan KB, Baker DJ, van Deursen JM, BubR1 alterations that reinforce mitotic surveillance act against aneuploidy and cancer. Elife 2016;5. https://doi.org/10.7554/eLife.16620. · DOI
- Ehninger D, Neff F, Xie K. Longevity, aging and rapamycin. Cell Mol Life Sci. 2014;71:4325–46. · DOI · Paper page
- Liu M, Howes A, Lesperance J, Stallcup WB, Hauser CA, Kadoya K, et al. Antitumor activity of rapamycin in a transgenic mouse model of ErbB2-dependent human breast cancer. Cancer Res. 2005;65:5325–36. · DOI · Paper page
- Woo Y, Lee HJ, Kim J, Kang SG, Moon S, Han JA, et al. Rapamycin promotes ROS-mediated cell death via functional inhibition of xCT expression in melanoma under γ-irradiation. Front Oncol. 2021;11:665420. · DOI
- Xing D, Orsulic S. A genetically defined mouse ovarian carcinoma model for the molecular characterization of pathway-targeted therapy and tumor resistance. Proc Natl Acad Sci USA. 2005;102:6936–41. · DOI · Paper page
- Amaral CL, Freitas LB, Tamura RE, Tavares MR, Pavan IC, Bajgelman MC, et al. S6Ks isoforms contribute to viability, migration, docetaxel resistance and tumor formation of prostate cancer cells. BMC Cancer. 2016;16:602. · DOI
- Lee S, Roh HS, Song SS, Shin J, Lee J, Bhang DH, et al. Loss of S6K1 but Not S6K2 in the tumor microenvironment suppresses tumor growth by attenuating tumor angiogenesis. Transl Oncol. 2020;13:100767. · DOI
- Lai KP, Cheung A, Ho CH, Tam NY, Li JW, Lin X, et al. Transcriptomic analysis reveals the oncogenic role of S6K1 in hepatocellular carcinoma. J Cancer. 2020;11:2645–55. · DOI
- Song X, Han X, Yu F, Zhang X, Chen L, Lv C. Polyamine-targeting Gefitinib Prodrug and its near-infrared fluorescent theranostic derivative for monitoring drug delivery and lung cancer therapy. Theranostics. 2018;8:2217–28. · DOI
- Thomas TJ, Thomas T, Cellular and animal model studies on the growth inhibitory effects of polyamine analogues on breast cancer. Med Sci. 2018;6. https://doi.org/10.3390/medsci6010024. · doi:10.3390/medsci6010024
- Chen Y, Zhuang H, Chen X, Shi Z, Wang X. Spermidine‑induced growth inhibition and apoptosis via autophagic activation in cervical cancer. Oncol Rep. 2018;39:2845–54.
- Boguszewski CL, Boguszewski M. Growth hormone’s links to cancer. Endocr Rev. 2019;40:558–74. · DOI · Paper page
- Chhabra Y, Waters MJ, Brooks AJ. Role of the growth hormone-IGF-1 axis in cancer. Expert Rev Endocrinol Metab. 2011;6:71–84. · DOI
- Takei Y, Saga Y, Mizukami H, Takayama T, Ohwada M, Ozawa K, et al. Overexpression of PTEN in ovarian cancer cells suppresses i.p. dissemination and extends survival in mice. Mol Cancer Ther. 2008;7:704–11. · DOI
- Garcia-Cao I, Song MS, Hobbs RM, Laurent G, Giorgi C, de Boer VC, et al. Systemic elevation of PTEN induces a tumor-suppressive metabolic state. Cell. 2012;149:49–62. · DOI · Paper page
- Saga Y, Mizukami H, Suzuki M, Kohno T, Urabe M, Ozawa K, et al. Overexpression of PTEN increases sensitivity to SN-38, an active metabolite of the topoisomerase I inhibitor irinotecan, in ovarian cancer cells. Clin Cancer Res. 2002;8:1248–52.
- Li B, Zhang J, Su Y, Hou Y, Wang Z, Zhao L, et al. Overexpression of PTEN may increase the effect of pemetrexed on A549 cells via inhibition of the PI3K/AKT/mTOR pathway and carbohydrate metabolism. Mol Med Rep. 2019;20:3793–801.
- Liu N, Rowley BR, Bull CO, Schneider C, Haegebarth A, Schatz CA, et al. BAY 80-6946 is a highly selective intravenous PI3K inhibitor with potent p110α and p110δ activities in tumor cell lines and xenograft models. Mol Cancer Ther. 2013;12:2319–30. · DOI · Paper page
- Soler A, Serra H, Pearce W, Angulo A, Guillermet-Guibert J, Friedman LS, et al. Inhibition of the p110α isoform of PI 3-kinase stimulates nonfunctional tumor angiogenesis. J Exp Med. 2013;210:1937–45. · DOI · Paper page
- Soler A, Figueiredo AM, Castel P, Martin L, Monelli E, Angulo-Urarte A, et al. Therapeutic benefit of selective inhibition of p110α PI3-Kinase in pancreatic neuroendocrine tumors. Clin Cancer Res. 2016;22:5805–17. · DOI
- Goulielmaki E, Bermudez-Brito M, Andreou M, Tzenaki N, Tzardi M, de Bree E, et al. Pharmacological inactivation of the PI3K p110δ prevents breast tumour progression by targeting cancer cells and macrophages. Cell Death Dis. 2018;9:678. · DOI
- deGraffenried LA, Friedrichs WE, Russell DH, Donzis EJ, Middleton AK, Silva JM, et al. Inhibition of mTOR activity restores tamoxifen response in breast cancer cells with aberrant Akt Activity. Clin Cancer Res. 2004;10:8059–67. · DOI · Paper page
- Podsypanina K, Lee RT, Politis C, Hennessy I, Crane A, Puc J, et al. An inhibitor of mTOR reduces neoplasia and normalizes p70/S6 kinase activity in Pten+/- mice. Proc Natl Acad Sci USA. 2001;98:10320–5. · DOI · Paper page
- Srivastava RK, Li C, Khan J, Banerjee NS, Chow LT, Athar M. Combined mTORC1/mTORC2 inhibition blocks growth and induces catastrophic macropinocytosis in cancer cells. Proc Natl Acad Sci USA. 2019;116:24583–92. · DOI
- Anisimov VN. Metformin for aging and cancer prevention. Aging. 2010;2:760–74. · DOI
- Chang HH, Moro A, Chou CEN, Dawson DW, French S, Schmidt AI, et al. Metformin decreases the incidence of pancreatic ductal adenocarcinoma promoted by diet-induced obesity in the conditional KrasG12D Mouse model. Sci Rep. 2018;8:5899. · DOI
- Chen K, Qian W, Jiang Z, Cheng L, Li J, Sun L, et al. Metformin suppresses cancer initiation and progression in genetic mouse models of pancreatic cancer. Mol Cancer. 2017;16:131. · DOI · Paper page
- Aljofan M, Riethmacher D. Anticancer activity of metformin: a systematic review of the literature. Future Sci OA. 2019;5:Fso410. · DOI · Paper page
- Pallavi R, Giorgio M, Pelicci PG. Insights into the beneficial effect of caloric/dietary restriction for a healthy and prolonged life. Front Physiol. 2012;3:318. · DOI
- Morioka T, Yamazaki S, Yanagihara H, Sunaoshi M, Kaminishi M, Kakinuma S. Calorie restriction suppresses the progression of radiation-induced intestinal tumours in C3B6F1 Apc (Min/+) Mice. Anticancer Res. 2021;41:1365–75. · DOI
- Kopeina GS, Senichkin VV, Zhivotovsky B. Caloric restriction—A promising anti-cancer approach: From molecular mechanisms to clinical trials. Biochim Biophys Acta Rev Cancer. 2017;1867:29–41. · DOI
- Gates AC, Bernal-Mizrachi C, Chinault SL, Feng C, Schneider JG, Coleman T, et al. Respiratory uncoupling in skeletal muscle delays death and diminishes age-related disease. Cell Metab. 2007;6:497–505. · DOI · Paper page
- Shrestha R, Johnson E, Byrne FL. Exploring the therapeutic potential of mitochondrial uncouplers in cancer. Mol Metab. 2021;51:101222. · DOI · Paper page
- Matheu A, Maraver A, Collado M, Garcia-Cao I, Cañamero M, Borras C, et al. Anti-aging activity of the Ink4/Arf locus. Aging Cell. 2009;8:152–61. · DOI · Paper page
- Modesitt SC, Ramirez P, Zu Z, Bodurka-Bevers D, Gershenson D, Wolf JK. In vitro and in vivo adenovirus-mediated p53 and p16 tumor suppressor therapy in ovarian cancer. Clin Cancer Res. 2001;7:1765–72.
- Zhou X, Singh M, Sanz Santos G, Guerlavais V, Carvajal LA, Aivado M, et al. Pharmacological activation of p53 triggers viral mimicry response thereby abolishing tumor immune evasion and promoting anti-tumor immunity. Cancer Discov. 2021;11:3090–105. https://doi.org/10.1158/2159-8290.CD-20-1741. · DOI · Paper page
- Ramos H, Soares MIL, Silva J, Raimundo L, Calheiros J, Gomes C, et al. A selective p53 activator and anticancer agent to improve colorectal cancer therapy. Cell Rep. 2021;35:108982. · DOI
- Wang Z, Sun Y. Targeting p53 for novel anticancer therapy. Transl Oncol. 2010;3:1–12. · DOI · Paper page
- Rohwer N, Kühl AA, Ostermann AI, Hartung NM, Schebb NH, Zopf D, et al. Effects of chronic low-dose aspirin treatment on tumor prevention in three mouse models of intestinal tumorigenesis. Cancer Med. 2020;9:2535–50. · DOI
- Guillem-Llobat P, Dovizio M, Bruno A, Ricciotti E, Cufino V, Sacco A, et al. Aspirin prevents colorectal cancer metastasis in mice by splitting the crosstalk between platelets and tumor cells. Oncotarget. 2016;7:32462–77. · DOI · Paper page
- Li XF, Xu BZ, Wang SZ. Aspirin inhibits the proliferation and migration of gastric cancer cells in p53-knockout mice. Oncol Lett. 2016;12:3183–6. · doi:10.3892/ol.2016.5067
- Yang C, Liu J, Wang Y, Tong J, Wu Y, Liu Y. Aspirin inhibits the proliferation of canine mammary gland tumor cells in vitro and in vivo. Transl Cancer Res. 2017;6:188–97. · doi:10.21037/tcr.2017.01.07
- Maity G, De A, Das A, Banerjee S, Sarkar S, Banerjee SK. Aspirin blocks growth of breast tumor cells and tumor-initiating cells and induces reprogramming factors of mesenchymal to epithelial transition. Lab Invest. 2015;95:702–17. · DOI
- Van Dyke T, Jacks T. Cancer modeling in the modern era: progress and challenges. Cell. 2002;108:135–44. · DOI · Paper page
- Frese KK, Tuveson DA. Maximizing mouse cancer models. Nat Rev Cancer. 2007;7:645–58. · DOI · Paper page
- Becher OJ, Holland EC. Genetically engineered models have advantages over xenografts for preclinical studies. Cancer Res. 2006;66:3355–8. discussion 3358-9 · DOI · Paper page
- Rera M, Clark RI, Walker DW. Intestinal barrier dysfunction links metabolic and inflammatory markers of aging to death in Drosophila. Proc Natl Acad Sci USA. 2012;109:21528–33. · DOI · Paper page
- Rera M, Clark RI, Walker DW. Why do old flies die? Aging. 2013;5:586–7. · DOI
- Biteau B, Karpac J, Supoyo S, Degennaro M, Lehmann R, Jasper H. Lifespan extension by preserving proliferative homeostasis in Drosophila. PLoS Genet. 2010;6:e1001159. · DOI · Paper page
- Wang L, Karpac J, Jasper H. Promoting longevity by maintaining metabolic and proliferative homeostasis. J Exp Biol. 2014;217:109–18. · DOI
- Rera M, Azizi MJ, Walker DW. Organ-specific mediation of lifespan extension: more than a gut feeling? Ageing Res Rev. 2013;12:436–44. · DOI · Paper page
- Choi NH, Kim JG, Yang DJ, Kim YS, Yoo MA. Age-related changes in Drosophila midgut are associated with PVF2, a PDGF/VEGF-like growth factor. Aging Cell. 2008;7:318–34. · DOI · Paper page
- Regan JC, Khericha M, Dobson AJ, Bolukbasi E, Rattanavirotkul N, Partridge L. Sex difference in pathology of the ageing gut mediates the greater response of female lifespan to dietary restriction. Elife. 2016;5:e10956. · DOI · Paper page
- Fan X, Liang Q, Lian T, Wu Q, Gaur U, Li D, et al. Rapamycin preserves gut homeostasis during Drosophila aging. Oncotarget. 2015;6:35274–83. · DOI
- Rodriguez-Fernandez IA, Tauc HM, Jasper H. Hallmarks of aging Drosophila intestinal stem cells. Mech Ageing Dev. 2020;190:111285. · DOI
- Choi NH, Lucchetta E, Ohlstein B. Nonautonomous regulation of Drosophila midgut stem cell proliferation by the insulin-signaling pathway. Proc Natl Acad Sci USA. 2011;108:18702–7. · DOI
- Wang L, Ryoo HD, Qi Y, Jasper H. PERK limits drosophila lifespan by promoting intestinal stem cell proliferation in response to ER stress. PLoS Genet. 2015;11:e1005220. · DOI
- Paredes JC, Welchman DP, Poidevin M, Lemaitre B. Negative regulation by amidase PGRPs shapes the Drosophila antibacterial response and protects the fly from innocuous infection. Immunity. 2011;35:770–9. · DOI · Paper page
- Hu DJ-K, Jasper H. Control of intestinal cell fate by dynamic mitotic spindle repositioning influences epithelial homeostasis and longevity. Cell Rep. 2019;28:2807–23.e2805. · DOI
- Guo L, Karpac J, Tran Susan L, Jasper H. PGRP-SC2 promotes gut immune homeostasis to limit commensal dysbiosis and extend lifespan. Cell. 2014;156:109–22. · DOI · Paper page
- Salazar AM, Resnik-Docampo M, Ulgherait M, Clark RI, Shirasu-Hiza M, Jones DL, et al. Intestinal Snakeskin limits microbial dysbiosis during aging and promotes longevity. iScience. 2018;9:229–43. · DOI
- Hwangbo DS, Gershman B, Tu MP, Palmer M, Tatar M. Drosophila dFOXO controls lifespan and regulates insulin signalling in brain and fat body. Nature. 2004;429:562–6. · DOI · Paper page
- Broughton SJ, Piper MD, Ikeya T, Bass TM, Jacobson J, Driege Y, et al. Longer lifespan, altered metabolism, and stress resistance in Drosophila from ablation of cells making insulin-like ligands. Proc Natl Acad Sci USA. 2005;102:3105–10. · DOI · Paper page
- Libert S, Zwiener J, Chu X, Vanvoorhies W, Roman G, Pletcher SD. Regulation of Drosophila life span by olfaction and food-derived odors. Science. 2007;315:1133–7. · DOI · Paper page
- Bjedov I, Toivonen JM, Kerr F, Slack C, Jacobson J, Foley A, et al. Mechanisms of life span extension by rapamycin in the fruit fly Drosophila melanogaster. Cell Metab. 2010;11:35–46. · DOI · Paper page
- Fridell YW, Hoh M, Kréneisz O, Hosier S, Chang C, Scantling D, et al. Increased uncoupling protein (UCP) activity in Drosophila insulin-producing neurons attenuates insulin signaling and extends lifespan. Aging. 2009;1:699–713. · DOI · Paper page
- Magwere T, Chapman T, Partridge L. Sex differences in the effect of dietary restriction on life span and mortality rates in female and male Drosophila melanogaster. J Gerontol A Biol Sci Med Sci. 2004;59:3–9. · DOI · Paper page
- Owusu-Ansah E, Song W, Perrimon N. Muscle mitohormesis promotes longevity via systemic repression of insulin signaling. Cell. 2013;155:699–712. · DOI · Paper page
- Giannakou ME, Goss M, Jünger MA, Hafen E, Leevers SJ, Partridge L. Long-lived Drosophila with overexpressed dFOXO in adult fat body. Science. 2004;305:361. · DOI · Paper page
- Rallis A, Navarro JA, Rass M, Hu A, Birman S, Schneuwly S, et al. Hedgehog signaling modulates glial proteostasis and lifespan. Cell Rep. 2020;30:2627–43.e2625. · DOI
- Wang MC, Bohmann D, Jasper H. JNK extends life span and limits growth by antagonizing cellular and organism-wide responses to insulin signaling. Cell. 2005;121:115–25. · DOI · Paper page
- Broughton SJ, Slack C, Alic N, Metaxakis A, Bass TM, Driege Y, et al. DILP-producing median neurosecretory cells in the Drosophila brain mediate the response of lifespan to nutrition. Aging Cell. 2010;9:336–46. · DOI · Paper page
- Chen H, Zheng X, Zheng Y. Age-associated loss of lamin-B leads to systemic inflammation and gut hyperplasia. Cell. 2014;159:829–43. · DOI · Paper page
- Ayyaz A, Li H, Jasper H. Haemocytes control stem cell activity in the Drosophila intestine. Nat Cell Biol. 2015;17:736–48. · DOI
- Han H, Pan C, Liu C, Lv X, Yang X, Xiong Y, et al. Gut–neuron interaction via Hh signaling regulates intestinal progenitor cell differentiation in Drosophila. Cell Discov. 2015;1:15006. · DOI
- Huang C, Xiong C, Kornfeld K. Measurements of age-related changes of physiological processes that predict lifespan of Caenorhabditis elegans. Proc Natl Acad Sci USA. 2004;101:8084–9. · DOI · Paper page
- Zhao Y, Gilliat AF, Ziehm M, Turmaine M, Wang H, Ezcurra M, et al. Two forms of death in ageing Caenorhabditis elegans. Nat Commun. 2017;8:15458. · DOI
- Zhao Y, Zhang B, Marcu I, Athar F, Wang H, Galimov ER, et al. Mutation of daf-2 extends lifespan via tissue-specific effectors that suppress distinct life-limiting pathologies. Aging Cell. 2021;20:e13324–e13324. · DOI
- Zhao Y, Wang H, Poole RJ, Gems D. A fln-2 mutation affects lethal pathology and lifespan in C. elegans. Nat Commun. 2019;10:5087. · DOI
- Sahin M. Targeted treatment trials for tuberous sclerosis and autism: no longer a dream. Curr Opin Neurobiol. 2012;22:895–901. · DOI
- Crino PB. Evolving neurobiology of tuberous sclerosis complex. Acta Neuropathol. 2013;125:317–32. · DOI
- Crowell B, Lee GH, Nikolaeva I, Dal Pozzo V, D’Arcangelo G, Complex neurological phenotype in mutant mice lacking Tsc2 in excitatory neurons of the developing forebrain(123). eNeuro 2015;2. · DOI
- Chen L, Oshima J. Werner Syndrome. J Biomed Biotechnol. 2002;2:46–54. · DOI · Paper page
- Lombard DB, Miller RA, Pletcher SD, Biology of Aging and Longevity. In: Halter JB, Ouslander JG, Studenski S, High KP, Asthana S, Supiano MA et al. (eds). Hazzard’s Geriatric Medicine and Gerontology, 7e. McGraw-Hill Education: New York, NY, 2017.
- Harman D. Aging: a theory based on free radical and radiation chemistry. J Gerontol. 1956;11:298–300. · DOI · Paper page
- McDonald RB “Cellular Aging” in Biology of Aging second edition, CRC Press 2019. · doi:10.1201/9780429030642
- Harman D. The free radical theory of aging: effect of age on serum copper levels. J Gerontol. 1965;20:151–3. · DOI · Paper page
- Doonan R, McElwee JJ, Matthijssens F, Walker GA, Houthoofd K, Back P, et al. Against the oxidative damage theory of aging: superoxide dismutases protect against oxidative stress but have little or no effect on life span in Caenorhabditis elegans. Genes Dev. 2008;22:3236–41. · DOI · Paper page
- Mesquita A, Weinberger M, Silva A, Sampaio-Marques B, Almeida B, Leão C, et al. Caloric restriction or catalase inactivation extends yeast chronological lifespan by inducing H2O2 and superoxide dismutase activity. Proc Natl Acad Sci USA. 2010;107:15123–8. · DOI · Paper page
- Zhang Y, Ikeno Y, Qi W, Chaudhuri A, Li Y, Bokov A, et al. Mice deficient in both Mn superoxide dismutase and glutathione peroxidase-1 have increased oxidative damage and a greater incidence of pathology but no reduction in longevity. J Gerontol A Biol Sci Med Sci. 2009;64:1212–20. · DOI · Paper page
- Harley CB, Vaziri H, Counter CM, Allsopp RC. The telomere hypothesis of cellular aging. Exp Gerontol. 1992;27:375–82. · DOI · Paper page
- Harley CB. Telomere loss: mitotic clock or genetic time bomb? Mutat Res. 1991;256:271–82. · DOI · Paper page
- Allsopp RC, Vaziri H, Patterson C, Goldstein S, Younglai EV, Futcher AB, et al. Telomere length predicts replicative capacity of human fibroblasts. Proc Natl Acad Sci USA. 1992;89:10114–8. · DOI · Paper page
- Hayflick L. The limited in vitro lifetime of human diploid cell strains. Exp Cell Res. 1965;37:614–36. · DOI · Paper page
- Goldstein S. Replicative senescence: the human fibroblast comes of age. Science. 1990;249:1129–33. · DOI · Paper page
- Hemann MT, Greider CW. Wild-derived inbred mouse strains have short telomeres. Nucleic Acids Res. 2000;28:4474–8. · DOI · Paper page
- Calado RT, Dumitriu B. Telomere dynamics in mice and humans. Semin Hematol. 2013;50:165–74. · DOI · Paper page
- Simons MJ. Questioning causal involvement of telomeres in aging. Ageing Res Rev. 2015;24:191–6. · DOI · Paper page
- Muñoz-Lorente MA, Cano-Martin AC, Blasco MA. Mice with hyper-long telomeres show less metabolic aging and longer lifespans. Nat Commun. 2019;10:4723. · DOI · Paper page
- Qi L, Strong MA, Karim BO, Armanios M, Huso DL, Greider CW. Short telomeres and ataxia-telangiectasia mutated deficiency cooperatively increase telomere dysfunction and suppress tumorigenesis. Cancer Res. 2003;63:8188–96.
- Feldser DM, Greider CW. Short telomeres limit tumor progression in vivo by inducing senescence. Cancer Cell. 2007;11:461–9. · DOI · Paper page
- Hahn WC, Meyerson M. Telomerase activation, cellular immortalization and cancer. Ann Med. 2001;33:123–9. · DOI · Paper page
- Yakoub AM. Cerebral organoids exhibit mature neurons and astrocytes and recapitulate electrophysiological activity of the human brain. Neural Regen Res. 2019;14:757–61. · DOI
- Rambani K, Vukasinovic J, Glezer A, Potter SM. Culturing thick brain slices: an interstitial 3D microperfusion system for enhanced viability. J Neurosci Methods. 2009;180:243–54. · DOI · Paper page
- Papaspyropoulos A, Tsolaki M, Foroglou N, Pantazaki AA. Modeling and targeting Alzheimer’s disease with organoids. Front Pharm. 2020;11:396. · DOI
- Rose MR, Evolutionary biology of aging. Oxford University Press, Oxford 1991.
- Aspinall R In: R Aspinall e. Aging of the Organs And Systems. Dordrecht: Springer 2003;3. · DOI
- Giaimo S, Traulsen A. The selection force weakens with age because ageing evolves and not vice versa. Nat Commun. 2022;13:686. · doi:10.1038/s41467-022-28254-3
- Nie C, Li Y, Li R, Yan Y, Zhang D, Li T, et al. Distinct biological ages of organs and systems identified from a multi-omics study. Cell Rep. 2022;38:110459. · DOI · Paper page
- Bellantuono I, de Cabo R, Ehninger D, Di Germanio C, Lawrie A, Miller J, et al. A toolbox for the longitudinal assessment of healthspan in aging mice. Nat Protoc. 2020;15:540–74. · DOI · Paper page
- Freund A. Untangling aging using dynamic, organism-level phenotypic networks. Cell Syst. 2019;8:172–81. · DOI
- Xie K, Fuchs H, Scifo E, Liu D, Aziz A, Aguilar-Pimentel JA et al. Deep Phenotyping and lifetime trajectories reveal limited effects of longevity regulators on the aging process in C57BL/6J Mice. bioRxiv 2022: 2022.2003.2025.485824. · DOI
- Hall H, Cooper BR, Qi G, Wijeratne AB, Mosley AL, Weake VM. Quantitative proteomic and metabolomic profiling reveals altered mitochondrial metabolism and folate biosynthesis pathways in the aging drosophila eye. Mol Cell Proteom. 2021;20:100127. · DOI
- Bajgiran M, Azlan A, Shamsuddin S, Azzam G, Halim MA. Data on RNA-seq analysis of Drosophila melanogaster during ageing. Data Brief. 2021;38:107413. · DOI
- Pacifico R, MacMullen CM, Walkinshaw E, Zhang X, Davis RL. Brain transcriptome changes in the aging Drosophila melanogaster accompany olfactory memory performance deficits. PLoS One. 2018;13:e0209405. · DOI
- Mangleburg CG, Wu T, Yalamanchili HK, Guo C, Hsieh YC, Duong DM, et al. Integrated analysis of the aging brain transcriptome and proteome in tauopathy. Mol Neurodegener. 2020;15:56. · DOI · Paper page
- Brown CJ, Kaufman T, Trinidad JC, Clemmer DE. Proteome changes in the aging Drosophila melanogaster head. Int J Mass Spectrom. 2018;425:36–46. · DOI
- Yang L, Cao Y, Zhao J, Fang Y, Liu N, Zhang Y. Multidimensional proteomics identifies declines in protein homeostasis and mitochondria as early signals for normal aging and age-associated disease in Drosophila. Mol Cell Proteom. 2019;18:2078–88. · DOI
- Laye MJ, Tran V, Jones DP, Kapahi P, Promislow DE. The effects of age and dietary restriction on the tissue-specific metabolome of Drosophila. Aging Cell. 2015;14:797–808. · DOI · Paper page
- Hoffman JM, Soltow QA, Li S, Sidik A, Jones DP, Promislow DE. Effects of age, sex, and genotype on high-sensitivity metabolomic profiles in the fruit fly, Drosophila melanogaster. Aging Cell. 2014;13:596–604. · DOI
- Behnke JA, Ye C, Moberg KH, Zheng JQ. A protocol to detect neurodegeneration in Drosophila melanogaster whole-brain mounts using advanced microscopy. STAR Protoc. 2021;2:100689. · DOI
- Tamura T, Chiang AS, Ito N, Liu HP, Horiuchi J, Tully T, et al. Aging specifically impairs amnesiac-dependent memory in Drosophila. Neuron. 2003;40:1003–11. · DOI · Paper page
- Tonoki A, Davis RL. Aging impairs intermediate-term behavioral memory by disrupting the dorsal paired medial neuron memory trace. Proc Natl Acad Sci. 2012;109:6319–24. · DOI
- Saitoe M, Saeki S, Hirano Y, Horiuchi J, Age-related memory impairment inDrosophila. In: Dubnau J (ed). Behavioral Genetics of the Fly (Drosophila Melanogaster). Cambridge University Press: Cambridge, 2014, 177-82. · doi:10.1017/cbo9780511920585.014
- Jones MA, Grotewiel M. Drosophila as a model for age-related impairment in locomotor and other behaviors. Exp Gerontol. 2011;46:320–5. · DOI
- Iliadi KG, Boulianne GL. Age-related behavioral changes in Drosophila. Ann N. Y Acad Sci. 2010;1197:9–18. · DOI
- Giebultowicz JM, Long DM. Aging and circadian rhythms. Curr Opin Insect Sci. 2015;7:82–86. · DOI
- Brown MK, Chan MT, Zimmerman JE, Pack AI, Jackson NE, Naidoo N. Aging induced endoplasmic reticulum stress alters sleep and sleep homeostasis. Neurobiol Aging. 2014;35:1431–41. · DOI
- Miller MS, Lekkas P, Braddock JM, Farman GP, Ballif BA, Irving TC, et al. Aging enhances indirect flight muscle fiber performance yet decreases flight ability in Drosophila. Biophys J. 2008;95:2391–401. · DOI
- Wessells RJ, Bodmer R. Cardiac aging. Semin Cell Dev Biol. 2007;18:111–6. · DOI
- Ocorr K, Akasaka T, Bodmer R. Age-related cardiac disease model of Drosophila. Mech Ageing Dev. 2007;128:112–6. · DOI
- Tarkhov AE, Alla R, Ayyadevara S, Pyatnitskiy M, Menshikov LI, Shmookler Reis RJ, et al. A universal transcriptomic signature of age reveals the temporal scaling of Caenorhabditis elegans aging trajectories. Sci Rep. 2019;9:7368. · DOI · Paper page
- Kaletsky R, Murphy CT. Transcriptional Profiling of C. elegans Adult Cells and Tissues with Age. Methods Mol Biol. 2020;2144:177–86. · DOI
- Kaletsky R, Yao V, Williams A, Runnels AM, Tadych A, Zhou S, et al. Transcriptome analysis of adult Caenorhabditis elegans cells reveals tissue-specific gene and isoform expression. PLoS Genet. 2018;14:e1007559. · DOI · Paper page
- Yasuda K, Ishii T, Suda H, Akatsuka A, Hartman PS, Goto S, et al. Age-related changes of mitochondrial structure and function in Caenorhabditis elegans. Mech Ageing Dev. 2006;127:763–70. · DOI
- Pickett CL, Dietrich N, Chen J, Xiong C, Kornfeld K. Mated progeny production is a biomarker of aging in Caenorhabditis elegans. G3. 2013;3:2219–32. · DOI
- McGee MD, Day N, Graham J, Melov S. cep-1/p53-dependent dysplastic pathology of the aging C. elegans gonad. Aging. 2012;4:256–69. · DOI
- Scharf A, Pohl F, Egan BM, Kocsisova Z, Kornfeld K, Reproductive aging in caenorhabditis elegans: from molecules to ecology. Front. Cell Dev Biol. 2021;9. · DOI
- Glenn CF, Chow DK, David L, Cooke CA, Gami MS, Iser WB, et al. Behavioral deficits during early stages of aging in Caenorhabditis elegans result from locomotory deficits possibly linked to muscle frailty. J Gerontol A Biol Sci Med Sci. 2004;59:1251–60. · DOI · Paper page
- Chow DK, Glenn CF, Johnston JL, Goldberg IG, Wolkow CA. Sarcopenia in the Caenorhabditis elegans pharynx correlates with muscle contraction rate over lifespan. Exp Gerontol. 2006;41:252–60. · DOI
- Pan CL, Peng CY, Chen CH, McIntire S. Genetic analysis of age-dependent defects of the Caenorhabditis elegans touch receptor neurons. Proc Natl Acad Sci USA. 2011;108:9274–9. · DOI · Paper page
- Tank EM, Rodgers KE, Kenyon C. Spontaneous age-related neurite branching in Caenorhabditis elegans. J Neurosci. 2011;31:9279–88. · DOI · Paper page
- Toth ML, Melentijevic I, Shah L, Bhatia A, Lu K, Talwar A, et al. Neurite sprouting and synapse deterioration in the aging Caenorhabditis elegans nervous system. J Neurosci. 2012;32:8778–90. · DOI · Paper page
- Hahm JH, Kim S, DiLoreto R, Shi C, Lee SJ, Murphy CT, et al. C. elegans maximum velocity correlates with healthspan and is maintained in worms with an insulin receptor mutation. Nat Commun. 2015;6:8919. · DOI · Paper page
- Hsu AL, Feng Z, Hsieh MY, Xu XZ. Identification by machine vision of the rate of motor activity decline as a lifespan predictor in C. elegans. Neurobiol Aging. 2009;30:1498–503. · DOI
- Kauffman AL, Ashraf JM, Corces-Zimmerman MR, Landis JN, Murphy CT. Insulin signaling and dietary restriction differentially influence the decline of learning and memory with age. PLoS Biol. 2010;8:e1000372. · DOI · Paper page
- Son HG, Altintas O, Kim EJE, Kwon S, Lee SV. Age-dependent changes and biomarkers of aging in Caenorhabditis elegans. Aging Cell. 2019;18:e12853. · DOI · Paper page
- Mészáros L, Hoffmann A, Wihan J, Winkler J. Current symptomatic and disease-modifying treatments in multiple system atrophy. Int J Mol Sci. 2020;21:2775. · DOI
- Hampel H, Frank R, Broich K, Teipel SJ, Katz RG, Hardy J, et al. Biomarkers for Alzheimer’s disease: academic, industry and regulatory perspectives. Nat Rev Drug Disco. 2010;9:560–74. · DOI · Paper page
- Cummings J, Fox N. Defining disease-modifying therapy for Alzheimer’s disease. J Prev Alzheimers Dis. 2017;4:109–15.
- Symptomatic vs. Disease-modifying therapies. In: Espay A, Stecher B (eds). Brain Fables: The Hidden History of Neurodegenerative Diseases and a Blueprint to Conquer Them. Cambridge University Press: Cambridge, 2020, 87–94. · DOI
- Richardson AM, R. Mechanism of food restriction: change of rate or change of set point. in The potential for nutritional modulation of aging processes (eds Ingram, DK, Baker, GT & Shock, NW) (Food & Nutrition Press) 1992:177–92.
- Brown-Borg HM, Borg KE, Meliska CJ, Bartke A. Dwarf mice and the ageing process. Nature. 1996;384:33. · DOI · Paper page
- Zhou Y, Xu BC, Maheshwari HG, He L, Reed M, Lozykowski M, et al. A mammalian model for Laron syndrome produced by targeted disruption of the mouse growth hormone receptor/binding protein gene (the Laron mouse). Proc Natl Acad Sci USA. 1997;94:13215–20. · DOI · Paper page
- Flurkey K, Papaconstantinou J, Miller RA, Harrison DE. Lifespan extension and delayed immune and collagen aging in mutant mice with defects in growth hormone production. Proc Natl Acad Sci USA. 2001;98:6736–41. · DOI · Paper page
- Dawlaty M, Baker D, Malureanu L, Jeganathan K, van Deursen J. BubR1 overexpression protects against tumorigenesis in mice. Cancer Res. 2008;68:LB-263–LB-263.
- Qian Y, Berryman DE, Basu R, List EO, Okada S, Young JA, et al. Mice with gene alterations in the GH and IGF family. Pituitary 2022;25:1–51 https://doi.org/10.1007/s11102-021-01191-y. · DOI
Cited by
Aging Hallmarks and Progression and Age-Related Diseases: A Landscape View of Research Advancement
Tenchov, R., Sasso, J. M., Wang, X., & Zhou, Q. A. (2024) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.3c00531 · Cited by 276
The exposome of healthy and accelerated aging across 40 countries
Hernandez, H., Santamaria-Garcia, H., Moguilner, S., Farina, F. R., Legaz, A., Prado, P., Cuadros, J., Gonzalez, L., Gonzalez-Gomez, R., Migeot, J., et al. (2025) · Nature Medicine · doi:10.1038/s41591-025-03808-2 · Cited by 71
Proteomic aging signatures across mouse organs and life stages
Scifo, E., Morsy, S., Liu, T., Xie, K., Schaaf, K., Bano, D., & Ehninger, D. (2025) · The EMBO Journal · doi:10.1038/s44318-025-00509-x · Cited by 10
Self-citationMulti-omics characterization of partial chemical reprogramming reveals evidence of cell rejuvenation
Mitchell, W., Goeminne, L. J. E., Tyshkovskiy, A., Zhang, S., Chen, J. Y., Paulo, J. A., Pierce, K. A., Choy, A. H., Clish, C. B., Gygi, S. P., et al. (2023) · doi:10.1101/2023.06.30.546730 · Cited by 2
Multi-omics characterization of partial chemical reprogramming reveals evidence of cell rejuvenation
Mitchell, W., Goeminne, L. J. E., Tyshkovskiy, A., Zhang, S., Chen, J. Y., Paulo, J. A., Pierce, K. A., Choy, A. H., Clish, C. B., Gygi, S. P., et al. (2024) · doi:10.7554/elife.90579.2
Metadata
- Authors
- Keshavarz, M., Xie, K., Schaaf, K., Bano, D., & Ehninger, D.
- Venue
- Molecular Psychiatry
- Published
- 2022-07-15
- Volume
- 28
- Issue
- 1
- Pages
- 242-255
- ISSN
- 1359-4184 (ISSN-L)
- 1476-5578
- OpenAlex
- W4285490897
- Cited by
- 118
- References
- 43
- FWCI
- 6.32
- Type
- journal article
- Language
- en
- Open access
- hybrid
- Licence
- creativecommons.org/licenses/by/4.0 (tdm)
- creativecommons.org/licenses/by/4.0 (vor)
- Funders
- Helmholtz Association (AMPro)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Targeting the “hallmarks of aging” to slow aging and treat age-related disease: fact or fiction? https://app.cochat.ai/papers/10.1038/s41380-022-01680-x
- The paper
- Keshavarz, M., Xie, K., Schaaf, K., Bano, D., & Ehninger, D. (2023). Targeting the “hallmarks of aging” to slow aging and treat age-related disease: fact or fiction? Molecular Psychiatry. https://doi.org/10.1038/s41380-022-01680-x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.